BELLS HEALTHCARE — Clopidogrel Importer Profile
Pharmaceutical Importer · #3 buyer for Clopidogrel · $2.1M import value · 66 shipments · UNITED KINGDOM · DGFT Verified
BELLS HEALTHCARE is the #3 importer of Clopidogrel from India with $2.1M in import value and 66 verified shipments. BELLS HEALTHCARE holds a 1.3% market share in Clopidogrel imports based in UNITED KINGDOM. The company sources from 2 verified suppliers across 22 formulations shipped to 1 country. Overall, BELLS HEALTHCARE imports 4 pharmaceutical products worth $11.9M across 4 therapeutic categories.
BELLS HEALTHCARE — Clopidogrel Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Clopidogrel to BELLS HEALTHCARE?
Verified from 66 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| STERIL-GENE LIFE SCIENCES PRIVATE LIMITED | $1.8M | 60 | 87.7% |
| STERIL GENE LIFE SCIENCES PRIVATE LIMITED | $252.8K | 6 | 12.3% |
BELLS HEALTHCARE sources Clopidogrel from 2 verified Indian suppliers based on 66 customs records. The primary supplier is STERIL-GENE LIFE SCIENCES PRIVATE LIMITED accounting for 87.7% of imports.
How Does BELLS HEALTHCARE Compare to Nearest Clopidogrel Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $4.7M | 186 | $25.3K |
| 2 | AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $4.5M | 91 | $50.0K |
| 3 | BELLS HEALTHCARE ★ | UNITED KINGDOM | $3.3M | 66 | $50.0K |
| 15 | ZENTIVA ITALIA SRL | ITALY | $3.2M | 65 | $49.2K |
| 6 | AUROLOGISTICS LLC | UNITED STATES | $3.0M | 59 | $50.0K |
BELLS HEALTHCARE ranks #3 among 1,234 Clopidogrel importers from India. Average shipment value of $50.0K compared to the market average of $42.4K. The closest competitors by value are APL SWIFT SERVICES (MALTA) LTD., and AUROLOGISTICS LLC (AUROBINDO PHARMA.
Where Does BELLS HEALTHCARE Import Clopidogrel To?
Destination countries from 66 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $2.1M | 66 | 100.0% |
BELLS HEALTHCARE imports Clopidogrel to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $2.1M.
What Clopidogrel Formulations Does BELLS HEALTHCARE Import?
| Formulation | Value | Shipments |
|---|---|---|
| CLOPIDOGREL 75 MG TABLETS (2X14`S) | $723.2K | 21 |
| CLOPIDOGREL 75 MG TABLETS 2X14`S | $429.4K | 10 |
| CLOPIDOGREL 75 MG TABLETS 2X14 S | $152.8K | 4 |
| CLOPIDOGREL 75 MG TABLETS (2X14`S)PCS | $105.6K | 12 |
| CLOPIDOGREL 75MG TABLETS 2X14 S | $50.0K | 1 |
| CLOPIDOGREL 75 MG TABLETS (207600X2X14`S) | $50.0K | 1 |
| CLOPIDOGREL 75 MG TABLETS (125300X2X14`S) | $50.0K | 1 |
| CLOPIDOGREL 75 MG TABLETS (83700X2X14`S) | $50.0K | 1 |
| CLOPIDOGREL 75 MG TABLETS (83220X2X14`S) | $50.0K | 1 |
| CLOPIDOGREL 75 MG TABLETS (83920X2X14`S) | $50.0K | 1 |
BELLS HEALTHCARE imports 22 distinct Clopidogrel formulations from India. The top formulation is CLOPIDOGREL 75 MG TABLETS (2X14`S) with 21 shipments worth $723.2K.
Regulatory Requirements: Importing Clopidogrel into United Kingdom
What BELLS HEALTHCARE and other importers must comply with to import Clopidogrel from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Clopidogrel
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Clopidogrel from India and How Much Does BELLS HEALTHCARE Import?
India exported $52.3M worth of Clopidogrel through 6,037 shipments from 416 suppliers to 137 countries, serving 1,234 buyers globally. BELLS HEALTHCARE imports $2.1M of this total, accounting for 1.3% of India's Clopidogrel exports with 66 shipments from UNITED KINGDOM. This is verified from 66 customs shipment records covering 22 distinct formulations.
What Is the Average Order Value for BELLS HEALTHCARE's Clopidogrel Imports?
BELLS HEALTHCARE's average Clopidogrel order value is $31.2K per consignment, based on 66 shipments totaling $2.1M. BELLS HEALTHCARE is based in UNITED KINGDOM and ranks #3 among all Clopidogrel importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Clopidogrel to BELLS HEALTHCARE?
BELLS HEALTHCARE sources Clopidogrel from 2 verified Indian suppliers: STERIL-GENE LIFE SCIENCES PRIVATE LIMITED ($1.8M, 87.7%), STERIL GENE LIFE SCIENCES PRIVATE LIMITED ($252.8K, 12.3%). This is based on 66 customs records.
How Does BELLS HEALTHCARE Compare to Other Clopidogrel Importers?
BELLS HEALTHCARE ranks #3 among 1,234 Clopidogrel importers from India with a 1.3% market share. The top 3 importers are ALLOGA UK AP7 ($8.0M), NORTHSTAR DISTRIBUTION CENTER 8912 ($6.5M), APL SWIFT SERVICES MALTA LTD ($4.7M). BELLS HEALTHCARE processed 66 shipments from UNITED KINGDOM.
About BELLS HEALTHCARE
BELLS HEALTHCARE imports 4 products worth $11.9M. Beyond Clopidogrel, top products include Prednisolone, Paracetamol, Tamoxifen. View the complete BELLS HEALTHCARE profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clopidogrel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clopidogrel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BELLS HEALTHCARE matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BELLS HEALTHCARE's capped import value divided by total capped export value for Clopidogrel across all Indian exporters.
- 5.Verified Records: This page is backed by 66 individual customs records matching BELLS HEALTHCARE importing Clopidogrel, covering 22 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 1,234+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clopidogrel Import Data for BELLS HEALTHCARE
Access order-level details, pricing data, supplier connections, and competitive analysis for BELLS HEALTHCARE's Clopidogrel imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BELLS HEALTHCARE
Full Company Profile →
4 products · $11.9M total trade · 4 categories
BELLS HEALTHCARE × Clopidogrel
Verified from customs records
Company Overview
Top Products by BELLS HEALTHCARE
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BELLS HEALTHCARE.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clopidogrel. For current order-level data, contact TransData Nexus.